Summary.-We have compared the actions of ADM and mAMSA in Chinese hamster V79 cells in vitro, using cell survival and sister-chromatid exchange as end-points.
tially growing cells, and both drugs are less effective in killing chronically hypoxic and plateau-phase cells. Cytotoxicity to thermotolerant cells (41°C for 16 h previously) shows little difference from that for exponential cells. Pre-treating cells with misonidazole under hypoxic conditions reduces the toxicity of both ADM and mAMSA. In addition, an ADM-resistant Chinese hamster cell line, 77A-177, was crossresistant to mAMSA. Finally, low equimolar sub-toxic doses of both drugs were found to cause similar increases in the levels of sister-chromatid exchanges in V79 cells. These results reveal no major difference in activity between ADM and mAMSA in vitro.
ADRIAMYCIN (ADM) is thought to be cytotoxic due to its ability to intercalate between adjacent base pairs in DNA (Zunino et al., 1972) . It has been used clinically since 1969 and has been shown to be effective in a variety of human tumours. However, the efficacy of this drug is limited by its cardiotoxicity (Carter, 1975) . Another drug which is thought to act by intercalation of DNA is 4'-1 (9-acridinyl) -amino]methanesulphon -m -anisidide (mAMSA, NSC 249992) (Gormley et al., 1978) . This acridine derivative, which was one of a series synthesized by Atwell et al. (1972) , has recently completed Phase I and II clinical studies (Legha et al., 1978 (Legha et al., , 1979 Schneider et al., 1979 Schneider et al., , 1980 and is now undergoing prospective randomized trials. Cell-kinetic studies in vitro have shown ADM and mAMSA to have similar effects, which has led to the suggestion that mAMSA may be an alternative to ADM in the clinic .
The present work was undertaken to compare directly the toxicity of ADM and mAMSA to mammalian cells in vitro. This was done using V79 cells with differing culture histories and a cell line with induced resistance to ADM. The response of cells to ADM and mAMSA after treatment with misonidazole was also examined, since in previous studies where misonidazole has been used in combination with alkylating agents a synergistic cytotoxicity has been seen (Rose et al., 1980; Stratford et al., 1980 (Smith et al., 1980; Rajaratnam et al., 1981) . Plateau-phase cells were taken from unfed suspension cultures which became density inhibited at a cell concentration of 1 2-1-6 x 106 cells/ml. Under these conditions, the pH of the culture medium had been reduced to around 6-9. Other experiments involving reduced pH were done with exponentially growing cells which had been cultured in medium at pH [6] [7] [8] for 16 h before drug treatment. Thermotolerant cells were prepared by maintaining log-phase cells at 41°C (pH 7 4) for 16 h (Stratford et al., 1981b The culture conditions described above were not inimical to our V79 cells, and all these cell populations had plating efficiencies > 9000 before treatment with cytotoxic drugs.
An ADM-resistant Chinese hamster cell line (77A-177, Belli, 1979) was sometimes also studied. These cells had originally been exposed to 0-1~tM ADM for 77 weeks, followed by a further 177 weeks growth in drug-free medium, during which time they retained their resistance to ADM. Some experiments involved pre-treatment with misonidazole (Stratford et al., 1980 whereas for 1 OtkM mAMSA survival is increased 100-fold. The cytotoxicity of ADM or mAMSA was unaffected, whether the pretreatment was with misonidazole in air for 2 h or with N2 alone for 2 h (data not shown). A comparison of the DNA-damaging effects of ADM and mAMSA was carried out using SCE as an end-point. The frequencies of SCE as a function of subtoxic doses of the drugs are summarized in the Table, and dose-response curves are illustrated in Fig. 6 . Fig. 7 shows a chromosome spread for a cell treated with ]0,M BrdU for 18 h; SCE were scored by counting the exchange sites (arrows in Fig. 7) . Fig 8 and 9 show the distribution of SCE per cell within the dividing population after treatment with either ADM or mAMSA. There is a dose-dependent increase in the incidence of SCE after treatment with either drug, though at higher concentrations ADM appears to be slightly more effective.
SCE experiments involved cells being treated with 10uM BrdU for 18 h. In drug-free controls it was found that this treatment alone reduced the surviving fraction to -0-8. However, little further reduction in the surviving fraction is seen when a lh exposure to 041 and 0 2Mm of either drug is given in combination with BrdU treatment.
DISCUSSION
In this study we have set out to compare in vitro the cytotoxic and DNA-damaging effects of two intercalating agents, ADM and mAMSA. Both drugs produce survival curves of similar shape for exponentially growing cells. It is not clear from our data whether the shape of the survival curves is due to heterogeneity of drug sensitivities. However, it has been suggested by others (Belli & Piro, 1977) .
Further, Tobey et al. (1976) showed that the differential toxicity of ADM for cycling vs non-cycling cells (produced by iso-leucine starvation) is much less than that reported here and in the work of others (Barranco et al., 1974; Twentyman, 1976 (Smith et al., 1980) . These cells are also more resistant than exponentially growing cells to mAMSA. Cells held at 41°C for long enough to modify their response to heat damage (Stratford et al., 1981a) or the cytotoxic action of some drugs (Stratford et al., 1981b) continue cycling, and this in turn is reflected in these cells having similar sensitivities to ADM and mAMSA when compared to exponentially growing cells held constantly at 37°C. Taken together these results are consistent with the proposal that the growth status of cells in vitro will be an important determinant of sensitivity to ADM or mAMSA.
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Cells held at pH 6-8 for 16 h before drug treatment continue cycling. However, the cells at this pH are slightly more resistant to both ADM and mAMSA when compared to exponentially growing cells held at pH 7-4. Both mAMSA and ADM are weak bases, with pKa values of 7-3 (Wilson et al., 1981) and 8-2 (Skovsgaard, 1977) respectively. Changes in drug uptake with associated changes in toxicity have been reported as a function of pH for cells exposed to ADM (Skovsgaard, 1977) . Further, the cytotoxicity of mAMSA has been reported to be maximal at pH 7-2 (Wilson et al., 1981) . The pH range 6-8-7'4 spans that in which tumour cells may be found in vivo and it may be important that at these values of pH the cytotoxic actions of ADM and mAMSA are similar.
The basic similarities between the cytotoxic effects of ADM and mAMSA are further demonstrated by the fact that a cell line with induced resistance to ADM shows cross-resistance to mAMSA. This cell line has also been shown to be crossresistant to Actinomycin D which has been attributed to genetically controlled membrane changes resulting in decreased drug uptake .
Cells given 5mM misonidazole for 2 h in N2 before exposure to either ADM or mAMSA become resistant to the cytotoxic actions of both intercalating agents. There is no such effect if cells are pretreated with 5mM misonidazole in air for 2 h, nor when cells are given N2 for 2 h with no misonidazole. The exposure to misonidazole in N2 reduces survival to 0-6; it is known that misonidazole shows cell-cycle specificity, in its cytotoxic action with cells in early S being most sensitive and late S/G2 cells most resistant (Whitmore & Gulyas, 1980; Stratford, 1980) . The published data on the age responses of cells to ADM and mAMSA have yielded differing results (Kim & Kim, 1972; Barranco, 1975; Bhuyan et al., 1980; Deaven et al., 1978; Roberts & Millar, 1980) . However, preliminary work with synchronized V79 cells (West, unpublished) (Au et al., 1981; Galloway & Wolff, 1979; Perry & Evans, 1975 proportion of non-differentially stained mitoses (1st divisions) appeared higher after treatment with 0 2,tM mAMSA than after the corresponding dose of ADM, suggesting that at these doses mAMSA may induce more mitotic delay than ADM. Taking these qualifications into account, it is nevertheless apparent that ADM and mAMSA induce SCE at a similar frequency.
In conclusion, we have demonstrated that the DNA damaging and cytotoxic effects of ADM and mAMSA are broadly similar, under a variety of test conditions in vitro. We suggest, therefore, that should any difference in effect be seen for these drugs in vivo or indeed clinically, this difference will have its origins in the pharmacology of the two drugs, i.e. their uptake, tumour penetration, metabolism and excretion, rather than in inherent differences in cell sensitivity.
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